Glucose Transporter Inhibitor DRB18 in the Treatment of Lung Cancer

Presenter Information

Lindsey Bachmann, Biological Sciences

Abstract

DRB18 is a new anticancer compound that blocks glucose uptake in cancer cells and works with other drugs to improve outcomes.

Keywords:

Biological Sciences, Cancer, Biomedical Sciences, Anticancer drugs, Cancer metabolism, video

Comments

.

Status

Undergraduate

Department

Biological Sciences

College

Honors Tutorial College

Campus

Athens

Faculty Mentor

Chen, Xiaozhuo

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-No Derivative Works 4.0 International License.

Streaming Media